Cons: should a patient with stage IA non-small cell lung cancer undergo invasive mediastinal staging?

Ítems similars

• Pros: should a patient with stage IA non-small cell lung cancer undergo invasive mediastinal staging?
  per: Obiols, Carme, et al.
  Publicat: (2016)
• Rebuttal from Dr. Decaluwé and Dr. Dooms
  per: Decaluwé, Herbert, et al.
  Publicat: (2016)
• Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?
  per: Metro, Giulio, et al.
  Publicat: (2018)
• Cons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?
  per: Metro, Giulio, et al.
  Publicat: (2018)
• Pros: long-term CT scan follow-up should be the standard of care in patients who are curatively treated for an early-stage non-small cell lung cancer
  per: Hanna, Waël C.
  Publicat: (2015)